14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Kidney Diseases in 3 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Imig, JD | 3 |
Jankiewicz, WK | 1 |
Khan, AH | 1 |
Campbell, WB | 1 |
Schmitz, JM | 1 |
Falck, JR | 1 |
2 reviews available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Kidney Diseases
Article | Year |
---|---|
Orally Active Epoxyeicosatrienoic Acid Analogs.
Topics: 8,11,14-Eicosatrienoic Acid; Administration, Oral; Animals; Blood Pressure; Cardiovascular Diseases; | 2017 |
Epoxyeicosatrienoic acids, hypertension, and kidney injury.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Antihypertensive Agents; Disease Models, Animal; Disease Progr | 2015 |
1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Kidney Diseases
Article | Year |
---|---|
Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics: 2019 Lewis K. Dahl Memorial Lecture.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Cardiovascular Diseases; Cytochrome P-450 En | 2020 |